Abstract:AIM: To evaluate the protective effect of NF-kappa B decoy oligodeoxynuleotides (ODNs) on ischemia/reperfusion (I/R) injury in rat liver graft.METHODS: Orthotopic syngeneic rat liver transplantation was performed with 3 h of cold preservation of liver graft in University of Wisconsin solution containing phosphorothioated double-stranded NF-kappa B decoy ODNs or scrambled ODNs. NF-kappa B decoy ODNs or scrambled ODNs were injected intravenously into donor and recipient rats 6 h and 1 h before operation, respectively. Recipients were sacrificed 0h to 16 h after liver graft reperfusion. NF-kappa B activity in the liver graft was analyzed by electrophoretic mobility shift assay (EMSA). Hepatic mRNA expression of TNF-alpha, IFN-gamma and intercellular adhesion molecule-1(ICAM-1) were determined by semiquantitative RT-PCR. Serum levels of TNF-alpha and IFN-gamma were measured by enzyme-linked immunosorbent assays (ELISA). Serum level of alanine transaminase (ALT) was measured using a diagnostic kit. Liver graft myeloperoxidase (MPO) content was assessed.RESULTS: NF-kappa B activation in liver graft was induced in a time -dependent fashion, and NF-kappa B remained activated for 16 h after graft reperfusion. NF-kappa B activation in liver graft was significant at 2 to 8 h and slightly decreased at 16 h after graft reperfusion. Administration of NF-kappa B decoy ODNs significantly suppressed NF-kappa B activation as well as mRNA expression of TNF-alpha, IFN-gamma and ICAM-1 in the liver graft. The hepatic NF-kappa B DNA binding activity [presented as integral optical density (IOD) value] in the NF-kappa B decoy ODNs treatment group rat was significantly lower than that of the I/R group rat (2.16 +/- 0.78 vs 36.78 +/- 6.35 and 3.06 +/- 0.84 vs 47.62 +/- 8.71 for IOD value after 4 h and 8 h of reperfusion, respectively, P < 0.001). The hepatic mRNA expression level of TNF-alpha, IFN-gamma and ICAM-1 [presented as percent of beta-actin mRNA(%)] in the NF-kappa B decoy ODNs treatment group rat was significantly lower than that of the I/R group rat (8.31 +/- 3.48 vs 46.37 +/- 10.65 and 7.46 +/- 3.72 vs 74.82 +/- 12.25 for hepatic TNF-alpha mRNA, 5.58 +/- 2.16 vs 50.46 +/- 9.35 and 6.47 +/- 2.53 vs 69.72 +/- 13.41 for hepatic IFN-gamma mRNA, 6.79 +/- 2.83 vs 46.23 +/- 8.74 and 5.28 +/- 2.46 vs 67.44 +/- 10.12 for hepatic ICAM-1 mRNA expression after 4 hours and 8 h of reperfusion, respectively, P < 0.001). Administration of NF-kappa B decoy ODNs almost completely abolished the increase of serum level of TNF-alpha and IFN-gamma induced by hepatic ischemia/reperfusion, the serum level (pg/ml) of TNF-alpha and IFN-gamma in the NF-kappa B decoy ODNs treatment group rat was significantly lower than that of the I/R group rat (42.7 +/- 13.6 vs 176.7 +/- 15.8 and 48.4 +/- 15.1 vs 216.8 +/- 17.6 for TNF-alpha level, 31.5 +/- 12.1 vs 102.1 +/- 14.5 and 40.2 +/- 13. 5 vs 118.6 +/- 16.7 for IFN-gamma level after 4 hours and 8 h of reperfusion, respectively, P < 0.001). Liver graft neutrophil recruitment indicated by MPO content and hepatocellular injury indicated by serum ALT level were significantly reduced by NF-kappa B decoy ODNs, the hepatic MPO content (A655) and serum ALT level (IU/L) in the NF-kappa B decoy ODNs treatment group rat was significantly lower than that of the I/R group rat (0.17 +/- 0.07 vs 1.12 +/- 0.25 and 0.46 +/- 0.17 vs 1.46 +/- 0.32 for hepatic MPO content, 71.7 +/- 33.2 vs 286.1 +/- 49.6 and 84.3 +/- 39.7 vs 467.8 +/- 62.3 for ALT level after 4 hours and 8 h of reperfusion, respectively, P < 0.001).CONCLUSION: The data suggest that NF-kappa B decoy ODNs protects against I/R injury in liver graft by suppressing NF-kappa B activation and subsequent expression of proinflammatory mediators. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.

Improvement of Recipient Survival after Small Size Graft Liver Transplantation in Rats with Preischemic Manipulation or Administering Antisense Against Nuclear Factor-Kappa B

Suppression of Liver Regeneration Affects Hepatic Graft Survival in Small-For-Size Liver Transplantation in Rats

Impaired Hepatic Regeneration by Ischemic Preconditioning in A Rat Model of Small-For-Size Liver Transplantation

Panax Notoginseng Saponins Preconditioning Protects Rat Liver Grafts from Ischemia/reperfusion Injury Via an Antiapoptotic Pathway.

SOD mimetic improves the function, growth, and survival of small-size liver grafts after transplantation in rats.

Optimized Postconditioning Algorithm Protects Liver Graft after Liver Transplantation in Rats.

The Protective Effect of Ischemic-preconditioning on the Graft of Rat Liver Transplantation

Effect of ischemic preconditioning on expression of nitric oxide synthase in rat small-for-size liver graft

Protective effect of Ginkgo Biloba leaves extracta preconditioning on liver graft in rat liver transplantation

The Protective Effect of Panax Notoginseng Saponins on the Transplanted Liver During Ischemia-Reperfusion Injury in Rat with Orthotopic Liver Transplantation

Protective Effect of Enos Overexpression Against Ischemia/reperfusion Injury in Small-for-size Liver Transplantation.

Nuclear Factor-Kappa B Decoy Oligodeoxynucleotides Attenuates Ischemia/Reperfusion Injury In Rat Liver Graft

Ischemic Preconditioning Improves Rat Kidney Allograft Function After Ischemia/Reperfusion Injury: The Role of Tumor Necrosis Factor-Alpha

In Vivo Suppressive Effect of Nuclear Factor-Kappa B Inhibitor on Neutrophilic Inflammation of Grafts after Orthotopic Liver Transplantation in Rats

Effect of extract of Ginkgo Biloba leaves preconditioning on the cell apoptosis and expression of bcl-2 and fas mRNA in rat transplanted liver tissue

Protective Effect of Remote Limb Ischemic Perconditioning on the Liver Grafts of Rats with a Novel Model

Impact of different ways of perfusion on the survival rate of small-for-size liver transplantation in rats

Protective Effect of L-Arginine Preconditioning on Ischemia and Reperfusion Injury Associated with Rat Small Bowel Transplantation

Impact of Panax Notoginseng Saponins Preconditioning on Apoptosis and the Expression of TNF-α, Caspase-3 in Rat Liver Transplantation

Retraction Note To: Approaching Treatment for Immunological Rejection of Living-Donor Liver Transplantation in Rats

Impact of Extract of Ginkgo Biloba Leaves Preconditioning on Expression of FasmRNA, Caspase-3 Mrna and Apoptosis in Rat Liver Transplantation